MIS BAIR (Melbourne Infant Study: BCG for Allergy & Infection Reduction)
A randomised, controlled trial to determine if BCG immunisation at birth prevents the development of allergy & infection in infants
Nigel Curtis
Murdoch Children’s Research Institute
National Health and Medical Research Council (NHMRC), Royal Children’s Hospital Foundation, University of Melbourne and Murdoch Children’s Research Institute
Prevention
Intervention
To assess whether the BCG vaccine will prevent food allergy, eczema and lower respiratory tract infections in the first 5 years of life.
Study participants randomised to group 1 received a single 0.05 mL intradermal injection of BCG Vaccine SSI or BCG 10 Vaccine over the distal insertion of the deltoid muscle onto the humerus approximately one third down the upper left arm.
1272 healthy newborns randomised in the first 10 days of life.
Recruitment completed September 2016. Data collection ongoing, through February 2022.
Study contact: [email protected]
Study website: www.misbair.org.au
ClinicalTrials.gov: https://clinicaltrials.gov/ct2/show/NCT01906853
In collaboration with the National Allergy Centre of Excellence, we maintain a list of studies recruiting participants in Australia for research into food, drug, insect and respiratory allergies. Sign up to receive an email alert each time a new study is added to this list.